(Total Views: 248)
Posted On: 10/07/2020 4:44:11 AM
Post# of 36566
https://disclosure.bursamalaysia.com/FileAcce...TTACHMENTS
As per this filing from Bintai. 2M is immediate on deal signing which is done on 6th and GNBT as to confirm the payment within 24 hrs
Another 600+ k before commercialization and 10M after that.
Contingent upon
Parties agree that Generex/NuGenerex shall at all aspects procure all documents, permits, consents and approvals for the full approval of the FDA for the said Vaccine application.
Only after Generex/NuGenerex has obtained the Full FDA approvals application, BHSB shall be responsible for all requirements of Malaysian Ministry of Health.
Timeline:
(v) In the event Generex/NuGenerex fails to secure the necessary FDA approvals within 6 months or within an approved reasonable amount of time thereafter, from the execution of this DLA and subsequently upon the request of BHSB, Generex shall reimburse BHSB the USD$2,000,000 advance within 30 days upon demand from BHSB.
As per this filing from Bintai. 2M is immediate on deal signing which is done on 6th and GNBT as to confirm the payment within 24 hrs
Another 600+ k before commercialization and 10M after that.
Contingent upon
Parties agree that Generex/NuGenerex shall at all aspects procure all documents, permits, consents and approvals for the full approval of the FDA for the said Vaccine application.
Only after Generex/NuGenerex has obtained the Full FDA approvals application, BHSB shall be responsible for all requirements of Malaysian Ministry of Health.
Timeline:
(v) In the event Generex/NuGenerex fails to secure the necessary FDA approvals within 6 months or within an approved reasonable amount of time thereafter, from the execution of this DLA and subsequently upon the request of BHSB, Generex shall reimburse BHSB the USD$2,000,000 advance within 30 days upon demand from BHSB.
(0)
(0)
